Laura Romero Perez

María Zambrano (Investigadora Distinguida)
lromero-ibis@us.es
Área de conocimiento: Anatomía Patológica
Departamento: Citología e Histología Normal y Patológica
Grupo: Sin Grupo
Tipo Año Título Fuente
Letter2022 Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma MOLECULAR CANCER
Artículo2021 Sarcoma classification by DNA methylation profiling NATURE COMMUNICATIONS
Artículo2021 Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer NATURE COMMUNICATIONS
Capítulo2021 Tissue Preservation and FFPE Samples: Optimized Nucleic Acids Isolation in Ewing Sarcoma Methods in molecular biology
Letter2021 Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma MOLECULAR CANCER
Capítulo2021 Western Blot Analysis in Ewing Sarcoma Methods in molecular biology
Artículo2020 A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas Cancer Immunology, Immunotherapy
Artículo2020 DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Artículo2020 High specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG positive Ewing sarcoma CANCERS
Artículo2020 Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma JOURNAL OF PATHOLOGY
Artículo2020 Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma INTERNATIONAL JOURNAL OF CANCER
Artículo2020 Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma NATURE COMMUNICATIONS
Corrección2020 Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma (Nature Communications, (2020), 11, 1, (2423), 10.1038/s41467-020-16244-2) NATURE COMMUNICATIONS
Artículo2019 Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes NATURE COMMUNICATIONS
Artículo2019 DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Artículo2019 Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity NATURE
Artículo2019 Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma INTERNATIONAL JOURNAL OF CANCER
Artículo2019 Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients EBIOMEDICINE
Artículo2019 Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma CLINICAL CANCER RESEARCH
Revisión2019 STAG mutations in cancer TRENDS IN CANCER
Artículo2019 Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma CELL DEATH & DISEASE
Artículo2016 Improving the management of Inherited Retinal Dystrophies by targeted sequencing of a population-specific gene panel SCIENTIFIC REPORTS
Artículo2015 A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer MODERN PATHOLOGY
Resumen congreso2015 Mutational profile of undifferentiated endometrial carcinoma suggests its origin from endometrioid carcinoma LABORATORY INVESTIGATION
Artículo2015 Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer ENDOCRINE-RELATED CANCER
Resumen congreso2015 Nuclear TAZ protein expression associates with the triple-negative phenotype in breast cancer LABORATORY INVESTIGATION
Resumen congreso2014 Molecular characterization through massive parallel sequencing unveils clues regarding origin of undifferentiated endometrial carcinomas EUROPEAN JOURNAL OF CANCER
Artículo2014 VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer ENDOCRINE-RELATED CANCER
Artículo2013 Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis Human Pathology
Artículo2013 Oncogene alterations in endometrial carcinosarcomas Human Pathology
Artículo2013 ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma MODERN PATHOLOGY
Artículo2012 MicroRNA-200 family modulation in distinct breast cancer phenotypes PLOS ONE
Artículo2011 Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma JOURNAL OF PATHOLOGY
Resumen congreso2011 Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. LABORATORY INVESTIGATION
Resumen congreso2011 Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. MODERN PATHOLOGY
Resumen congreso2011 Molecular alterations in Endometrial Carcinosarcomas (ECS). MODERN PATHOLOGY
Resumen congreso2011 Molecular alterations in Endometrial Carcinosarcomas (ECS). LABORATORY INVESTIGATION
Este investigador no ha dirigido/tutorizado tesis

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2020 31/12/2022 Investigador/a Study of the prognostic and functional role of mesenchymal stem cell markers Endoglin and ALCAM in the disease progression of Clear cell sarcomas (CCS) and Desmoplastic small Round cell tumours (DSRCT) (P18-RT-735) Junta de Andalucía (Consejería de Economía y Conocimiento) (Autonómico)
El investigador no tiene ningún resultado de investigación asociado